Could Piperacillin Be the Lyme Disease Breakthrough We Need?
A recent study published in Science Translational Medicine by researchers at Northwestern University has generated cautious optimism in the Lyme disease community. The study found that an older antibiotic—piperacillin—was able to clear Borrelia burgdorferi, the bacteria that causes Lyme disease, in mice at doses 100 times lower than doxycycline. This is noteworthy. Doxycycline has long […]
Could Piperacillin Be the Lyme Disease Breakthrough We Need? Read More »